Testimony, Comments, & Letters

FederalState
;

Support for PrEP DC Act of 2025 (B26-0159)

Oct 30, 2025

Today we testify in support of the PrEP DC Act of 2025 (B26-0159) introduced by Councilmember Zachary Parker and co-introduced by eight other councilmembers. As the District continues to make progress in reducing the number of HIV infections, it must do everything possible in its power to ensure people who have a reason to protect themselves against HIV have access to all available prevention tools. That includes PrEP, which are incredible drugs that prevent HIV if people can access and afford them.

read more

Support for Ohio S.B. 207 to ban copay accumulators

Oct 20, 2025

When patients are forced to forego their medications due to high costs, the consequences are severe, not just for individual health outcomes, but also for public health and healthcare system costs. Policies that limit access to copay assistance exacerbate these challenges, disproportionately affecting those who are already vulnerable. Senate Bill 207 represents an essential safeguard against harmful insurer practices, ensuring equitable access to life-saving treatments for Ohioans.

read more

Oregon PDAB comments on Rx affordability and transparency

Oct 10, 2025

These recommendations will help ensure that savings flow directly to patients, preserve access to community and safety-net pharmacies, and strengthen programs like 340B that sustain care for vulnerable populations. Oregon’s leadership in advancing practical, patient-focused solutions can serve as a model for other states seeking to balance affordability with access and innovation. Thank you for the opportunity to comment and for your ongoing leadership on behalf of Oregon patients. We look forward to supporting the Board’s work as these recommendations move forward to the legislature.

read more

Support for Wisconsin copay accumulator ban

Oct 8, 2025

By passing Senate Bill 203, Wisconsin will join 25 other states, the District of Columbia, and Puerto Rico in protecting consumers purchasing insurance on the private market. This legislation ensures that copay assistance counts toward cost-sharing obligations, preventing patients from facing insurmountable financial barriers to their medications.

read more

Amicus brief in support of Iowa’s copay assistance law

Oct 8, 2025

HIV+Hep filed an amicus brief in support of Iowa’s PBM reform law that requires copay assistance to count for Rx’s not only in ACA plans but for the first time, employer plans. PBMs contend it is unlawful under ERISA. In our brief we explain to the US 8th Circuit Court of Appeals why it is not.

read more

Search

Categories

Tags

ACA Appropriations Biden administration CDC co-pay accumulators Congress copay copay accumulator Copay accumulators Copay assistance Cost-sharing COVID-19 Drug Pricing FDA Gay men healthcare Hepatitis Hepatitis B hepatitis C Hepatitis Prevention HHS HIV HIV Prevention Insurers Medicaid medicare Medicare Part D NAIC NIH PBM PBMs PrEP Prescription Drugs Private Insurance Ryan White Program state STDs Syringe services Testing transparency Treatment Trump administration women

Recent Testimony, Letters, Comments

Pin It on Pinterest